OBJECTIVE: To predict the impact on tobacco use in the US of a "harm reduction" policy that requires that the smokeless tobacco product meet low nitrosamine standards, but could be marketed with a warning label consistent with the evidence of relative health risks. METHODS: Low nitrosamine smokeless tobacco (LN-SLT) and cigarette use are predicted by a panel of experts using a modified Delphi approach. We specify a thought experiment to isolate the changes that would occur after the new LN-SLT policy was implemented. RESULTS: The panel predicted that the new policy would accelerate a decrease in smoking prevalence from 1.3 to 3.1 percentage points over 5 years compared to the current SLT product policy, with greater effects on males than females. Introduction of the new product was also predicted to result in modest additional use of SLT overall, with the greatest increases among males who initiated tobacco use under the new policy. CONCLUSION: An overall consensus was reached that the introduction of a new LN-SLT product under strict regulations would increase SLT use, but reduce overall smoking prevalence. This reduction would likely yield substantial health benefits, but uncertainties surround the role of marketing and other tobacco control policies.
OBJECTIVE: To predict the impact on tobacco use in the US of a "harm reduction" policy that requires that the smokeless tobacco product meet low nitrosamine standards, but could be marketed with a warning label consistent with the evidence of relative health risks. METHODS: Low nitrosamine smokeless tobacco (LN-SLT) and cigarette use are predicted by a panel of experts using a modified Delphi approach. We specify a thought experiment to isolate the changes that would occur after the new LN-SLT policy was implemented. RESULTS: The panel predicted that the new policy would accelerate a decrease in smoking prevalence from 1.3 to 3.1 percentage points over 5 years compared to the current SLT product policy, with greater effects on males than females. Introduction of the new product was also predicted to result in modest additional use of SLT overall, with the greatest increases among males who initiated tobacco use under the new policy. CONCLUSION: An overall consensus was reached that the introduction of a new LN-SLT product under strict regulations would increase SLT use, but reduce overall smoking prevalence. This reduction would likely yield substantial health benefits, but uncertainties surround the role of marketing and other tobacco control policies.
Authors: Matthew C Rousu; Richard J O'Connor; James F Thrasher; Kristie M June; Maansi Bansal-Travers; James Pitcavage Journal: Prev Med Date: 2013-12-07 Impact factor: 4.018
Authors: Karen Messer; Maya Vijayaraghavan; Martha M White; Yuyan Shi; Cindy Chang; Kevin P Conway; Anne Hartman; Megan J Schroeder; Wilson M Compton; John P Pierce Journal: Addict Behav Date: 2015-07-04 Impact factor: 3.913
Authors: Jessica L Burris; Amy E Wahlquist; Anthony J Alberg; K Michael Cummings; Kevin M Gray; Elizabeth Garrett-Mayer; Matthew J Carpenter Journal: Addict Behav Date: 2016-07-15 Impact factor: 3.913
Authors: Karin A Kasza; Maansi Bansal-Travers; Richard J O'Connor; Wilson M Compton; Anna Kettermann; Nicolette Borek; Geoffrey T Fong; K Michael Cummings; Andrew J Hyland Journal: Nicotine Tob Res Date: 2013-12-27 Impact factor: 4.244
Authors: Matthew J Carpenter; Amy E Wahlquist; Jessica L Burris; Kevin M Gray; Elizabeth Garrett-Mayer; K Michael Cummings; Anthony J Alberg Journal: Tob Control Date: 2016-04-12 Impact factor: 7.552
Authors: David T Levy; Christopher J Cadham; Luz Maria Sanchez-Romero; Marie Knoll; Nargiz Travis; Zhe Yuan; Yameng Li; Ritesh Mistry; Clifford E Douglas; Jamie Tam; Aylin Sertkaya; Kenneth E Warner; Rafael Meza Journal: Nicotine Tob Res Date: 2021-10-07 Impact factor: 5.825